Kendra Adams
Director of Finance/CFO chez C4 THERAPEUTICS, INC.
Fortune : 670 259 $ au 31/03/2024
Profil
Kendra R.
Adams is currently the Chief Financial Officer & Treasurer at C4 Therapeutics, Inc. She previously worked as the Director-Investor Relations at ARIAD Pharmaceuticals, Inc. and as the VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc. Ms. Adams completed her undergraduate degree at Hamilton College (New York).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0,12% | 07/03/2024 | 82 039 ( 0,12% ) | 670 259 $ | 31/03/2024 |
Postes actifs de Kendra Adams
| Sociétés | Poste | Début |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director of Finance/CFO | 18/09/2023 |
Anciens postes connus de Kendra Adams
| Sociétés | Poste | Fin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| ARIAD PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Formation de Kendra Adams
| Hamilton College (New York) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
